Christian Orlik
Associate Director - In Vitro Biology Heidelberg Pharma
Dr. Christian Orlik is Associate Director In Vitro Biology at Heidelberg Pharma Research GmbH, a pharma company located near Heidelberg (Germany), mainly conducting research and development of anti-cancer drugs. He obtained his bachelor’s and master’s degree in molecular biology focusing on virology in 2014, followed by a PhD in immunology at Heidelberg University Hospital. He joined Heidelberg Pharma in 2020 as a group leader and started his work on establishing cell-based assay for the functional evaluation of ADCs based on RNA polymerase II inhibitor alpha-Amanitin. In his current position, he is responsible for the ADC Research with focus on the pre-clinical development of new Amanitin based ADCs.
Seminars
- Discussing the limitations of cell-line derived xenograft models
- Deciphering Mode-of Action of ATACs in heterogenous patient-derived xenograft models
- Leveraging findings from the PDX model to better understand resistance mechanism of ADCs and ATACs
